Technology
& evidence
The approach, intended operating conditions, available evidence, and known limitations.
ENDOSCOPEX / MEDICAL TECHNOLOGY & IP
Patent-pending innovation in physiological sensing, device safety, connected care, and clinical workflows.

01 — THE COMPANY
EndoscopeX develops medical technologies around clinical and operational needs.
Our portfolio connects product development with intellectual-property strategy.
A DEDICATED FOCUS. A CONNECTED PORTFOLIO.
Our sensing and monitoring identity, within the broader EndoscopeX portfolio.
Explore VitalSignX
Measurement. Calibration. Context.INTELLECTUAL PROPERTY AT THE CORE
We develop the technical approach and IP strategy together, considering clinical relevance and potential commercial applications.
Discuss the IP portfolioTHE TECHNICAL FOUNDATION
We start with a clinical or operational need, then assess the proposed contribution and supporting evidence.
02 — OUR FOCUS
Explore the clinical focus and potential applications of each area.
Useful monitoring starts with reliable measurement.
Sensing and calibration approaches for the integrity and utility of physiological measurements.
POTENTIAL APPLICATIONSPatient monitoring and physiological measurement platforms.
Explore VitalSignXDevice integrity matters in everyday clinical use.
Protective systems and device integrity concepts shaped by clinical workflows and use conditions.
POTENTIAL APPLICATIONSMedical device manufacturers and clinical device platforms.
Discuss this areaMeasurements need context.
Concepts connecting measurements with the context needed to make healthcare information more useful.
POTENTIAL APPLICATIONSConnected monitoring, digital health, and clinical information platforms.
Discuss this areaTechnology must fit the clinical workflow.
Platform architecture for clinical protocols and the workflows that support them.
POTENTIAL APPLICATIONSClinical workflow software and integrated care platforms.
Discuss this areaNonconfidential overview. Technical details, development status, and supporting evidence are discussed separately for each technology.
03 — THE EVALUATION FRAMEWORK
A clear view of the asset, the evidence, and the work ahead.
The approach, intended operating conditions, available evidence, and known limitations.
Asset scope, current filing status, ownership, and relevant rights or obligations.
Current stage, intended use, next milestones, and development dependencies.
Product alignment, implementation requirements, and commercial assumptions.
04 — LEADERSHIP

Experience across enterprise healthcare, digital health, and connected care.
Abdul Muhsin leads EndoscopeX’s technology and commercial strategy.
Previously a Regional Vice President at Masimo, he led enterprise growth across major U.S. health systems.
View professional background05 — STRATEGIC COLLABORATION
For medical-technology companies, licensing teams, and strategic investors.
Explore a company, portfolio, or selected-asset transaction with a defined scope and rationale.
Assess a technology’s relevance to your product roadmap, intended application, and licensing scope.
Discuss capital or complementary capabilities to support development, integration, and commercialization.
CONFIDENTIAL INQUIRIES
Introduce your organization and the area of interest.
Discuss your objectives and preferred transaction pathway.
Agree confidentiality and review scope where there is mutual interest.